BioSpace News Archive

ScreenPro is a Screening and Medical Technology company. ScreenPro provides turnkey screening solutions with alerting software, GoStop.

Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) has accepted its Investigational New Drug (IND) application for JS014.

Broadening of Intellectual Property Portfolio for These Two NCES Clearly Defines Development Pathway for the Next Generation of Psychedelic Medicines to Treat Addiction

The Company also expects to see increased liquidity in it’s shares as a result of the dual listing.

Due to Venowave’s composition, manufacturing of the device remains uninterrupted.

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) (“Cardiol” or the “Company”), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, is pleased to announce that the Company’s virtual Annual General and Special Meeting of Shareholders (the “AGM”) will be webcast on June 29, 2021, at 4:30 p.m. EDT.

The market is estimated to grow with a CAGR of 36.2% from 2020-2027.

The market is estimated to grow with a CAGR of 13.0% from 2018-2025.

Valbiotis announces the implementation of the TOTUM•63 mode of action clinical study by the Institute of nutrition and functional foods at Laval University in Quebec City, in partnership with Nestlé Health Science.

The American Diabetes Association®, along with the nation’s leading diabetes organizations, unveiled Let’s Talk Insulin , a campaign commemorating the 100th anniversary of the discovery of insulin.